163 related articles for article (PubMed ID: 36324268)
1. A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance.
Haring MPD; Elfrink AKE; Oudmaijer CAJ; Andel PCM; Furumaya A; de Jong N; Willems CJJM; Huits T; Sijmons JML; Belt EJT; Bosscha K; Consten ECJ; Coolsen MME; van Duijvendijk P; Erdmann JI; Gobardhan P; de Haas RJ; van Heek T; Lam HD; Leclercq WKG; Liem MSL; Marsman HA; Patijn GA; Terkivatan T; Zonderhuis BM; Molenaar IQ; Te Riele WW; Hagendoorn J; Schaapherder AFM; IJzermans JNM; Buis CI; Klaase JM; de Jong KP; de Meijer VE;
Hepatol Commun; 2023 Jan; 7(1):e2110. PubMed ID: 36324268
[TBL] [Abstract][Full Text] [Related]
2. Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
Vernuccio F; Ronot M; Dioguardi Burgio M; Cauchy F; Choudhury KR; Dokmak S; Soubrane O; Valla D; Zucman-Rossi J; Paradis V; Vilgrain V
Radiology; 2020 May; 295(2):361-372. PubMed ID: 32181728
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
4. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update.
Tse JR; Felker ER; Naini BV; Shen L; Shen J; Lu DSK; Kamaya A; Raman SS
Radiographics; 2023 Mar; 43(3):e220134. PubMed ID: 36821508
[TBL] [Abstract][Full Text] [Related]
6. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
8. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
[TBL] [Abstract][Full Text] [Related]
9. Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
Costa AF; Kajal D; Pereira A; Atri M
Eur Radiol; 2017 Apr; 27(4):1704-1712. PubMed ID: 27436025
[TBL] [Abstract][Full Text] [Related]
10. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O
Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437
[TBL] [Abstract][Full Text] [Related]
11. European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.
Laurent A; Dokmak S; Nault JC; Pruvot FR; Fabre JM; Letoublon C; Bachellier P; Capussotti L; Farges O; Mabrut JY; Le Treut YP; Ayav A; Suc B; Soubrane O; Mentha G; Popescu I; Montorsi M; Demartines N; Belghiti J; Torzilli G; Cherqui D; Hardwigsen J;
HPB (Oxford); 2016 Sep; 18(9):748-55. PubMed ID: 27593592
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.
Zulfiqar M; Sirlin CB; Yoneda N; Ronot M; Hecht EM; Chernyak V; Matsui O; Bastati N; Ba-Ssalamah A; Chatterjee D; Bashir M; Fowler KJ
J Magn Reson Imaging; 2020 Jun; 51(6):1630-1640. PubMed ID: 31418986
[TBL] [Abstract][Full Text] [Related]
13. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
15. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI.
Denecke T; Steffen IG; Agarwal S; Seehofer D; Kröncke T; Hänninen EL; Kramme IB; Neuhaus P; Saini S; Hamm B; Grieser C
Eur Radiol; 2012 Aug; 22(8):1769-75. PubMed ID: 22437921
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
[No Abstract] [Full Text] [Related]
17. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
18. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.
Gregory J; Paisant A; Paulatto L; Raynaud L; Bertin C; Kerbaol A; Vullierme MP; Paradis V; Vilgrain V; Ronot M
Eur J Radiol; 2020 Jul; 128():109027. PubMed ID: 32361381
[TBL] [Abstract][Full Text] [Related]
19. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
20. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A
AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
